Liabilities, Current of Pharma-Bio Serv, Inc. from 31 Oct 2010 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Pharma-Bio Serv, Inc. quarterly Liabilities, Current in USD history and change rate from 31 Oct 2010 to 31 Jul 2025.
  • Pharma-Bio Serv, Inc. Liabilities, Current for the quarter ending 31 Jul 2025 was $1,658,894, a 13% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

Pharma-Bio Serv, Inc. Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,658,894 -$240,382 -13% 31 Jul 2025 10-Q 15 Sep 2025 2025 Q3
Q1 2025 $1,780,233 -$417,100 -19% 30 Apr 2025 10-Q 16 Jun 2025 2025 Q2
Q4 2024 $3,420,462 -$257,907 -7% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q1
Q3 2024 $1,887,166 -$266,515 -12% 31 Oct 2024 10-Q 15 Sep 2025 2025 Q3
Q2 2024 $1,899,276 -$551,006 -22% 31 Jul 2024 10-Q 16 Sep 2024 2024 Q3
Q1 2024 $2,197,333 -$47,523 -2.1% 30 Apr 2024 10-Q 14 Jun 2024 2024 Q2
Q4 2023 $3,678,369 +$1,716,909 +88% 31 Jan 2024 10-Q 18 Mar 2024 2024 Q1
Q3 2023 $2,153,681 +$45,962 +2.2% 31 Oct 2023 10-K 29 Jan 2025 2024 FY
Q2 2023 $2,450,282 +$291,793 +14% 31 Jul 2023 10-Q 14 Sep 2023 2023 Q3
Q1 2023 $2,244,856 +$53,552 +2.4% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q2
Q4 2022 $1,961,460 -$360,334 -16% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 $2,107,719 -$561,451 -21% 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q2 2022 $2,158,489 -$202,966 -8.6% 31 Jul 2022 10-Q 14 Sep 2022 2022 Q3
Q1 2022 $2,191,304 -$1,086,429 -33% 30 Apr 2022 10-Q 14 Jun 2022 2022 Q2
Q4 2021 $2,321,794 -$3,213,339 -58% 31 Jan 2022 10-Q 17 Mar 2022 2022 Q1
Q3 2021 $2,669,170 -$1,123,623 -30% 31 Oct 2021 10-K 30 Jan 2023 2022 FY
Q2 2021 $2,361,455 -$1,391,181 -37% 31 Jul 2021 10-Q 14 Sep 2021 2021 Q3
Q1 2021 $3,277,733 +$565,986 +21% 30 Apr 2021 10-Q 14 Jun 2021 2021 Q2
Q4 2020 $5,535,133 +$3,588,858 +184% 31 Jan 2021 10-Q 17 Mar 2021 2021 Q1
Q3 2020 $3,792,793 +$122,253 +3.3% 31 Oct 2020 10-K 11 Feb 2022 2021 FY
Q2 2020 $3,752,636 +$1,650,087 +78% 31 Jul 2020 10-Q 14 Sep 2020 2020 Q3
Q1 2020 $2,711,747 +$775,452 +40% 30 Apr 2020 10-Q 15 Jun 2020 2020 Q2
Q4 2019 $1,946,275 -$105,304 -5.1% 31 Jan 2020 10-Q 16 Mar 2020 2020 Q1
Q3 2019 $3,670,540 +$1,104,868 +43% 31 Oct 2019 10-K 01 Feb 2021 2020 FY
Q2 2019 $2,102,549 +$48,190 +2.3% 31 Jul 2019 10-Q 16 Sep 2019 2019 Q3
Q1 2019 $1,936,295 -$14,963 -0.77% 30 Apr 2019 10-Q 14 Jun 2019 2019 Q2
Q4 2018 $2,051,579 +$566,980 +38% 31 Jan 2019 10-Q 18 Mar 2019 2019 Q1
Q3 2018 $2,565,672 +$1,022,752 +66% 31 Oct 2018 10-K 29 Jan 2020 2019 FY
Q2 2018 $2,054,359 +$647,782 +46% 31 Jul 2018 10-Q 14 Sep 2018 2018 Q3
Q1 2018 $1,951,258 +$552,075 +39% 30 Apr 2018 10-Q 14 Jun 2018 2018 Q2
Q4 2017 $1,484,599 -$93,418 -5.9% 31 Jan 2018 10-Q 19 Mar 2018 2018 Q1
Q3 2017 $1,542,920 -$615,618 -29% 31 Oct 2017 10-K 29 Jan 2019 2018 FY
Q2 2017 $1,406,577 -$265,059 -16% 31 Jul 2017 10-Q 14 Sep 2017 2017 Q3
Q1 2017 $1,399,183 -$353,382 -20% 30 Apr 2017 10-Q 14 Jun 2017 2017 Q2
Q4 2016 $1,578,017 +$82,934 +5.5% 31 Jan 2017 10-Q 17 Mar 2017 2017 Q1
Q3 2016 $2,158,538 +$34,688 +1.6% 31 Oct 2016 10-K 29 Jan 2018 2017 FY
Q2 2016 $1,671,636 -$80,888 -4.6% 31 Jul 2016 10-Q 14 Sep 2016 2016 Q3
Q1 2016 $1,752,565 -$222,265 -11% 30 Apr 2016 10-Q 14 Jun 2016 2016 Q2
Q4 2015 $1,495,083 -$698,494 -32% 31 Jan 2016 10-Q 16 Mar 2016 2016 Q1
Q3 2015 $2,123,850 -$501,737 -19% 31 Oct 2015 10-K 31 Jan 2017 2016 FY
Q2 2015 $1,752,524 -$511,248 -23% 31 Jul 2015 10-Q 14 Sep 2015 2015 Q3
Q1 2015 $1,974,830 -$445,424 -18% 30 Apr 2015 10-Q 15 Jun 2015 2015 Q2
Q4 2014 $2,193,577 -$97,726 -4.3% 31 Jan 2015 10-Q 17 Mar 2015 2015 Q1
Q3 2014 $2,625,587 -$554,864 -17% 31 Oct 2014 10-K 29 Jan 2016 2015 FY
Q2 2014 $2,263,772 -$7,886 -0.35% 31 Jul 2014 10-Q 15 Sep 2014 2014 Q3
Q1 2014 $2,420,254 -$60,026 -2.4% 30 Apr 2014 10-Q 16 Jun 2014 2014 Q2
Q4 2013 $2,291,303 +$91,795 +4.2% 31 Jan 2014 10-Q 17 Mar 2014 2014 Q1
Q3 2013 $3,180,451 +$404,933 +15% 31 Oct 2013 10-K 29 Jan 2015 2014 FY
Q2 2013 $2,271,658 +$174,146 +8.3% 31 Jul 2013 10-Q 16 Sep 2013 2013 Q3
Q1 2013 $2,480,280 +$577,003 +30% 30 Apr 2013 10-Q 14 Jun 2013 2013 Q2
Q4 2012 $2,199,508 +$136,314 +6.6% 31 Jan 2013 10-Q 18 Mar 2013 2013 Q1
Q3 2012 $2,775,518 +$251,881 +10% 31 Oct 2012 10-K 29 Jan 2014 2013 FY
Q2 2012 $2,097,512 +$143,585 +7.3% 31 Jul 2012 10-Q 14 Sep 2012 2012 Q3
Q1 2012 $1,903,277 30 Apr 2012 10-Q 14 Jun 2012 2012 Q2
Q4 2011 $2,063,194 31 Jan 2012 10-Q 16 Mar 2012 2012 Q1
Q3 2011 $2,523,637 +$1,088,923 +76% 31 Oct 2011 10-K 29 Jan 2013 2012 FY
Q2 2011 $1,953,927 31 Jul 2011 10-Q 14 Sep 2011 2011 Q3
Q3 2010 $1,434,714 31 Oct 2010 10-K/A 31 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.